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Abstract
Objective: To estimate the incidence of epilepsy in children with Zika-related mi-
crocephaly in the first 24 months of life; to characterize the associated clinical and 
electrographic findings; and to summarize the treatment responses.
Methods: We followed a cohort of children, born during the 2015-2016 Zika virus 
(ZIKV) epidemic in Brazil, with congenital microcephaly and evidence of congenital 
ZIKV infection on neuroimaging and/or laboratory testing. Neurological assessments 
were performed at ≤3, 6, 12, 15, 18, 21, and 24 months of life. Serial electroencepha-
lograms were performed over the first 24 months.
Results: We evaluated 91 children, of whom 48 were female. In this study sample, 
the cumulative incidence of epilepsy was 71.4% in the first 24 months, and the main 
type of seizure was infantile spasms (83.1%). The highest incidence of seizures oc-
curred between 3 and 9 months of age, and the risk remained high until 15 months 
of age. The incidence of infantile spasms peaked between 4 and 7 months and was 
followed by an increased incidence of focal epilepsy cases after 12 months of age. 
Neuroimaging results were available for all children, and 100% were abnormal. 
Cortical abnormalities were identified in 78.4% of the 74 children evaluated by com-
puted tomography and 100% of the 53 children evaluated by magnetic resonance im-
aging. Overall, only 46.1% of the 65 children with epilepsy responded to treatment. 
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1 |  INTRODUCTION
In 2015, an outbreak of microcephaly was reported in the 
northeast part of Brazil. Zika virus (ZIKV) was identified as 
the teratogenic agent, and intrauterine ZIKV infections were 
observed to have repercussions for the formation and devel-
opment of the fetal nervous system.1,2
To address the public health emergency of congenital 
Zika syndrome (CZS), the Microcephaly Epidemic Research 
Group (MERG; http://www.cpqam.fiocr uz.br/merg/) was 
formed in late 2015 and subsequently initiated three epidemi-
ological investigations: a case-control study of microcephaly, 
for which the results have been published,3‒5 a cohort study 
of pregnant women with rash,6 and a cohort of children with 
potential prenatal exposure to ZIKV. In addition, MERG re-
ported on a large case series of children with microcephaly2 
and proposed an initial description of CZS.7
In severe cases, children congenitally infected with ZIKV 
develop microcephaly, which has a clinical presentation marked 
by significant craniofacial disproportion as well as severe 
motor, cognitive, and sensory impairment.8,9 Neuroimaging 
studies have demonstrated that common features of microce-
phalic children include severe diffuse atrophy of the cerebral 
volume (especially of the supratentorial compartment), ven-
triculomegaly, cerebral-subcortical punctate calcifications, and 
cortical developmental disorders, primarily lissencephaly.9
Of clinical significance, lissencephaly is considered to be 
a major contributor to pediatric epilepsy cases10,11 for which 
there is an early onset of seizures that are difficult to control 
with the use of antiseizure medications.12 As lissencephaly has 
been a common finding among the neuroimaging of patients 
with CZS,9,12 it is hypothesized that there may be an increased 
risk for the occurrence of early epilepsy in children with 
Zika-related microcephaly, as suggested in the initial cases se-
ries.13‒16 Using data collected from a cohort of children born 
with microcephaly during the 2015-2016 ZIKV epidemic in 
northeast Brazil,2 this study aims to (1) estimate the incidence 
of epilepsy during the first 24 months of life, (2) characterize 
the associated clinical manifestations and electrographic find-
ings, and (3) summarize the treatment responses.
2 |  MATERIALS AND METHODS
The children participating in this study were followed using 
standardized medical assessments between October 2015 
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The most commonly used medication was sodium valproate with or without benzodi-
azepines, levetiracetam, phenobarbital, and vigabatrin.
Significance: Zika-related microcephaly was associated with high risk of early 
epilepsy. Seizures typically began after the third month of life, usually as infantile 
spasms, with atypical electroencephalographic abnormalities. The seizure control 
rate was low. The onset of seizures in the second year was less frequent and, when it 
occurred, presented as focal epilepsy.
K E Y W O R D S
congenital Zika syndrome, epilepsy, microcephaly, seizure, Zika virus
Key Points
• Epilepsy is a common and early finding in chil-
dren with Zika-related microcephaly
• Epileptic encephalopathy with spasms occurred in 
the majority of cases during the first year of life
• Hypsarrhythmia was not a frequent EEG finding 
for the epileptic encephalopathy cases; focal epi-
lepsy was the most common type observed in the 
second year
• Seizure control rate was low
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and April 2018 as part of the MERG Children's Bidirectional 
Cohort based in Recife, Pernambuco, Brazil. The Oswaldo 
Cruz University Hospital Research Ethics Committee pro-
vided ethical approval for this study (Presentation Certificate 
for Ethical Appreciation—CAAE 52803316.8.0000.5192), and 
those legally responsible for the infants signed informed con-
sent forms for study participation. All research was conducted 
in accordance with the Declaration of Helsinki and the codes 
and regulations of Brazil regarding research on human subjects.
2.1 | Study participants
The participants in the study included children diagnosed with 
microcephaly who were born between June 2015 and April 
2016 (ie, the period corresponding to the peak of the micro-
cephaly epidemic in Pernambuco state). Participants were clas-
sified as confirmed cases of CZS when they had laboratory 
evidence of ZIKV infection and as highly probable cases when 
they presented with abnormal neuroimaging findings and nega-
tive laboratory results for other congenital infections.17
Microcephaly was defined as a head circumference at 
least two standard deviations below the mean for age and 
sex; microcephaly cases were further classified as severe 
with a head circumference at least three standard deviations 
below the mean.18,19 For children born at term (ie, gesta-
tional age ≥ 37 weeks), head circumference z scores were 
calculated according to the World Health Organization 
(WHO) growth chart.18 using WHO Anthro software (https :// 
who.int/nutgr owthd b/softw are/en/). For premature infants, 
age was corrected in weeks, and head circumference z 
scores were calculated according to the Intergrowth curve.19
Infants who underwent only one assessment at a very 
early age (ie, ≤3 months) were excluded from the analyses.
2.2 | Participant evaluations
Neurological assessments were performed, according to 
the study protocol, by the MERG multidisciplinary teams 
in the neuropediatric outpatient clinic of the Oswaldo 
Cruz University Hospital (Recife, Pernambuco, Brazil) at 
the ages of ≤3, 6, 12, 15, 18, 21, and 24 months of life. 
Additional information for this study was retrieved from 
outpatient medical records and through interviews with 
caregivers. Laboratory evaluations for congenital infec-
tions were based on the analysis of cerebrospinal fluid 
(CSF) and/or blood collected during the first days of life 
and tested by capture-IgM enzyme-linked immunosorbent 
assay for IgM antibodies.20,21
All children underwent computed tomography (CT) and/
or magnetic resonance imaging (MRI) according to med-
ical indication. The Brazilian Ministry of Health guidelines 
recommend CT for the initial investigation of children with 
microcephaly. For those children who did not have MRI by the 
end of the second year of life, this examination was requested.
The cohort follow-up included serial electroencephalo-
grams (EEGs), which were performed using the International 
10-20 system, with differentiated montages for neonates at 
very early ages or participants with a very small head circum-
ference, and with 21 scalp electrodes in those aged >6 months. 
The digital EEG recordings were obtained during spontaneous 
sleep, lasting at least 30 minutes, using Neuromap or EMSA 
Medical Equipment systems, with a sensitivity of 7 or 10 µV/
mm and filters of low frequency of 0.5 Hz and high frequency 
of 70 Hz. The recording speed was 1.5 or 3.0 cm/s according 
to child age. They were analyzed in standard and/or differen-
tiated bipolar and longitudinal montages for neonates, when 
appropriate. The type of epilepsy was characterized by the 
most severe pattern recorded at any time within the period. The 
occurrence of hypsarrhythmia at any time determined the clas-
sification in this modality. A blinded analysis was performed 
separately by two neurophysiologists certified by the Brazilian 
Society of Clinical Neurophysiology board. The EEG results 
were categorized according to the revised glossary of terms 
most commonly used by clinical electroencephalographers22 
and classic descriptions of hypsarrhythmia as (1) background 
rhythm disorganization only; (2) EEG with a focal epileptiform 
abnormality (EA) pattern (ie, a small area in one hemisphere 
with epileptiform abnormality)22; (3) a multifocal epileptiform 
abnormality (ie, more than two independent epileptogenic 
regions present in both hemispheres)22; (4) a generalized EA 
(ie, an abnormality in diffuse bilateral synchronous projec-
tion)22; (5) hypsarrhythmia (ie, an abnormal pattern with very 
high-amplitude slow waves and multifocal spikes and sharp 
waves in all cortical areas, with disorganized and asynchronous 
appearance in classic form or increased interhemispheric syn-
chronization, asymmetrical, consistent or predominant single 
focus, episodes of voltage attenuation or fragmentation, and/
or primarily slow activity in variants forms)22‒24; and (6) EA 
with more than one pattern, usually multifocal and general-
ized, with a continuous occurrence but without the asynchrony 
and high-voltage characteristics defining hypsarrhythmia.22 
The agreement between the EEG readings by the two neuro-
physiologists was assessed by kappa coefficient. Discordant 
analyses were reassessed by joint review, and final classifica-
tions were reached by consensus.
2.3 | Study variables and 
statistical analyses
The incidence of epilepsy was defined as the age of the 
child at first seizure. Epilepsy was defined by the occur-
rence of seizure as reported by the caregiver, recorded 
in home videos, or witnessed by the attending physician. 
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From these data, the cumulative incidence of epilepsy was 
evaluated using a Kaplan-Meier approach. For this method, 
cumulative incidence was estimated as 1 − Si, where Si is 
the cumulative probability of remaining free of seizures, 
calculated as the product of the conditional survival prob-
abilities for all preceding intervals up to time i. For the 
survival analyses, follow-up was censored if the participant 
was lost to follow-up, died from other causes, or reached 
the end of the study (ie, 24 months of age). Age-related pat-
terns in epilepsy prevalence and seizure types were evalu-
ated across the following time periods: 0 to <3 months, 3 
to <6  months, 6 to <9  months, 9 to <12  months, 12 to 
<15  months, 15 to <18  months, 18 to <21  months, and 
21-24 months.
Epilepsy was described by (1) the type of seizure ac-
cording to the International League Against Epilepsy clas-
sifications,25 (2) the EEG findings, and (3) the associated 
use of antiseizure medications (ASMs). To minimize the 
misdiagnosis of spasms and nonepileptic events, a detailed 
medical history was undertaken to identify triggers for 
startle response, behavior before and after events, relation-
ship to sleep and wakefulness, typical events, and the po-
tential for suppression of events by limb restraint or other 
maneuvers.
Response to antiseizure treatment was defined, for focal 
epileptic syndrome, as a period of at least 6  months sei-
zure-free from the seventh month of age26 and, for epileptic 
syndromes with spasms, as a period of at least 28 consecutive 
days seizure-free.27
3 |  RESULTS
The study included 91 children with microcephaly who 
were evaluated over the first 2 years of life during a median 
of four outpatient visits (Table 1). The analytical cohort 
comprised 48 females and 43 males. Overall, 88 (96.7%) 
participants were considered to have severe microcephaly. 
CSF samples from 60 children and blood samples from 23 
children were tested for ZIKV; 52 were ZIKV-IgM+ in 
CSF and two were ZIKV-IgM+ in blood. All participants 
underwent CT and/or MRI neuroimaging (CT & MRI, 
n = 36; CT alone, n = 38; MRI alone, n = 17;), and 100% 
of them presented with abnormalities commonly found 
in congenital ZIKV infection, including corticosubcorti-
cal calcifications, cortical developmental disorders with 
simplification of the gyral pattern (pachygyria/agyria/lis-
sencephaly) or polymicrogyria, and cortical atrophy with 
ventriculomegaly.
Of the 91 infants included in this study, 65 (71.4%) devel-
oped epilepsy during follow-up (Figure 1) with an incidence 
of 6.3 cases per 100 person-months. The earliest case of ep-
ilepsy was observed at 5 days of age, and the incidence rate 
peaked at between 4 and 7 months of age. The median age for 
first unprovoked seizure was 6  months (interquartile range 
= 4-8 months). The incidence of epilepsy by age group and 
the cumulative incidence are shown in Table 2. By the ninth 
month of age, 52.7% of participating children had presented 
with epilepsy, and by the end of the second year, this percent-
age increased to 71.4%.
The main types of seizure and the most common epileptic 
syndromes are shown in Table 3. Whereas epileptic spasms 
were the most common type of seizure in the first year of life, 
focal seizures predominated in the second year.
Of the 55 children who had infantile spasms, two had 
their first seizures classified as isolated focal seizures at 2 
and 3 months of age, but then developed new onset infantile 
spasms at 22 and 10 months, respectively. Two other children 
had an isolated generalized seizure at 5 days of age and at 
3 months of age and then developed infantile spasms at 12 
and 6 months, respectively.
Ten children experienced focal epilepsy. One initially 
had spasm attacks at 12 months, which were promptly con-
trolled with ASM, before developing focal seizures later at 
15 months. This child and two others experienced only two 
seizures prior to control. Two of three children who had 
weekly seizures responded to treatment. Three children who 
had daily seizures did not respond to treatment. For one child, 
T A B L E  1  Clinical, laboratory, and neuroimaging findings 
among 91 children with Zika-related microcephaly
Clinical characteristics
Median (P25-
P75)/patients, 
n (%)
Evaluations per child 4 (2-5)
Sex
Male 43 (47.3%)
Female 48 (52.7%)
Microcephaly
<−2 SD 3 (3.3%)
<−3 SD 88 (96.7%)
Epilepsy
Yes 65 (71.4%)
No 26 (28.6%)
Cerebral spinal fluid
IgM or RT-PCR positive 53/61 (86.9%)
Brain computer tomography
Calcifications 68/74 (91.9%)
Ventriculomegaly 66/74 (89.2%)
Simplified gyral pattern 58/74 (78.4%)
Brain magnetic resonance imaging
Malformation of cortical development 53/53 (100%)
Decreased brain volume 44/48 (91.7%)
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seizure frequency was uncertain, but this child was among 
those who did not respond to treatment.
In the EEG evaluation, the kappa index for the concor-
dance between the evaluators was 82.9%. Of the 26 nonepi-
leptic participants, the EEGs of 15 were analyzed, of which 
13 presented focal or multifocal epileptiform abnormalities 
and two had no paroxysms (Table 3). Only two of the 65 
infants with epilepsy presented with no epileptiform abnor-
malities, although disorganization of the background rhythms 
was apparent. Some participants presented several patterns of 
epileptiform abnormality at different times during the first 2 
years of age. Among the 65 epileptic participants evaluated 
by EEG, the most frequent patterns observed were focal epi-
leptiform abnormalities (53.2%) and multifocal abnormalities 
(22.8%; Figure 2). An additional 15% experienced multifocal 
epileptiform abnormalities associated with generalized dis-
charges but without other characteristics of hypsarrhythmia, 
such as high amplitude, asynchrony, or continuous incidence. 
Only two participants presented a typical pattern of hypsar-
rhythmia (Table 3).
The most commonly used antiepileptic drugs were sodium 
valproate, levetiracetam, benzodiazepines, phenobarbital, and 
vigabatrin; distribution of use depended in part on availability 
and/or cost. Treatment was initiated with the minimum recom-
mended daily dosage and was increased weekly or biweekly up 
to the maximum dose recommended or tolerated (ie, due to the 
emergence of adverse effects). In children who were <3 months 
of age, the first treatment regimen was phenobarbital, which 
was later replaced by sodium valproate in most cases. In chil-
dren aged ≥3 months, treatment began with valproate alone or 
in combination with benzodiazepine, followed by levetiracetam 
and vigabatrin. Carbamazepine and/or lamotrigine were regi-
mens most commonly used in focal seizures. Although vigaba-
trin is considered the preferential treatment for infantile spasms, 
only seven patients had access to this medication, due to eco-
nomic constraints. Adrenocorticotrophic hormone (ACTH) was 
not used because it has not been made available by the Brazilian 
Ministry of Health. As CZS is a novel syndrome with uncer-
tainties regarding the viral persistence in the body and brain, 
steroid therapy in high doses was avoided in these microce-
phalic children.
Responses to antiseizure treatment were evaluated in two 
periods (ie, during the first 12 months and by 24 months). In 
the first period, 51 of the 65 participants with epilepsy were 
assessed. One child was not evaluated because their seizures 
began close to the 12th month. In the first period, 10 of 51 
(19.6%) evaluated patients achieved seizure control. In the 
second period, 64 of the 65 participants with epilepsy were 
F I G U R E  1  The cumulative incidence 
of epileptic seizures in the first months of 
life of infants with microcephaly due to Zika 
virus
T A B L E  2  Incidence of epilepsy by age range during the first 
24 months of life
Age at onset, 
mo
Epilepsy/
patients 
followed up
Incidence of 
epilepsy, %
Cumulative 
incidence
First year
0 to <3 4/91 4.4% —
3 to <6 28/87 32.2% 35.2%
6 to <9 16/59 27.1% 52.7%
9 to <12 7/43 16.3% 60.4%
Second year
12 to <15 7/36 19.4% 68.1%
15 to <18 1/29 3.4% 69.2%
18 to <21 1/28 3.6% 70.3%
21 to 24 1/27 3.7% 71.4%
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assessed, and only 20 (30.8%) responded to antiseizure treat-
ment. Considering both periods, the total rate of response to 
treatment was 46.1%. The response to treatment was better 
in patients with focal epilepsy, especially in those cases with 
early age at seizure onset (Table 3). Epileptic encephalopathy 
with spasm (ie, West syndrome and spasm without hypsar-
rhythmia) was refractory to several drug combinations.
4 |  DISCUSSION
In this study, we describe the incidence and characteris-
tics of epilepsy in 91 infants with CZS-associated micro-
cephaly during the first 2 years of life. Over the duration of 
follow-up, 71.4% of the microcephalic children experienced 
epilepsy, with a peak in incidence between the fourth and 
seventh months. Spasms were the predominant manifestation 
of seizure; however, EEG findings were not always typical 
of West syndrome. After 12 months of age, the incidence of 
epilepsy decreased, and most new onset seizures were focal 
in presentation. All children were observed to have abnormal 
neuroimaging, with notable alterations in the development 
of the cerebral cortex and varying degrees of lissencephaly 
(ie, pachygyria/agyria). Only 46.1% of the participants with 
epilepsy responded to antiseizure treatment by the end of 
follow-up.
The hypothesis that Zika-related microcephaly is asso-
ciated with a high risk of developing early epilepsy (ie, in 
 
Age at onset of epilepsy
0 to <3 mo 3 to <12 mo 12-24 mo
Incidence, 
n = 91, (%)
4 (4.3%) 51 (56%) 10 (11%)
Type of first 
seizure
2 focal
1 spasms
1 generalized
3 focal
47 spasms as first seizurea
1 generalized
6 focalb
4 spasms
Epileptic 
syndrome
1 focal epileptic
1 epileptic 
encephalopathy 
with infantile 
spasms
1 generalized 
seizure only
1 focal seizure 
only
2 focal epileptic
49 epileptic encephalopathy 
with infantile spasmsa
7 focal epileptic
5 epileptic 
encephalopathy 
with infantile 
spasmsc
EEG findings 2 focal 
epileptiform 
abnormality
2 generalized 
epileptiform 
abnormality
2 background rhythm 
disorganization
26 focal epileptiform 
abnormality
11 multifocal epileptiform 
abnormality
10 multifocal generalized plus 
epileptiform abnormality
2 hypsarrhythmia
7 focal 
epileptiform 
abnormality
3 multifocal 
epileptiform 
abnormality
Response to 
treatment at 
12 mo
None 10/51 (19.6%) epileptic 
encephalopathy with infantile 
spasms
—
Response to 
treatment at 
24 mo
2/4 (50%) focal 
epileptic
14/51 (27.4%) epileptic 
encephalopathy with infantile 
spasms
4/10 (40%): 3 
focal epileptic; 
1 epileptic 
encephalopathy 
with infantile 
spasms
Abbreviation: EEG, electroencephalographic.
aTwo patients had spasms as a second type for a total of 49 spasms cases. 
bOne patient developed spasms near 12 months, but controlled rapidly. After 3 months, he developed focal 
epilepsy, which remained uncontrolled at the end of follow-up. 
cOne patient had an isolated focal seizure at 2 months and developed spasms at 22 months. 
T A B L E  3  Clinical and EEG 
characteristics of epilepsy in infants with 
microcephaly during the first 24 months of 
life and proportion of infants with seizure 
control
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the first 24 months of life) was confirmed in this cohort. At 
the end of 24 months, nearly three-quarters of the monitored 
children had epileptic seizures, an incidence similar to that 
described in other studies of children with extensive lissen-
cephaly.11,28 Other recent studies of microcephaly cases asso-
ciated with congenital ZIKV infections have reported either 
similar15 or lower rates.12,13,15,16 Two factors may underlie 
the difference in rates. The first is the age range assessed. 
The study by Oliveira-Filho and colleagues13 reported an in-
cidence of 47% in infants monitored in only the first 4 months 
of life.12 As the age range for observation increased, the per-
centage of affected children increased to 50% in the study by 
Moura da Silva et al,12 which assessed infants up to 8 months, 
and to 67% in infants assessed up to 1 year of age in the study 
by van der Linden and colleagues,15 which was the similar 
to our finding at 12  months. Our study confirmed that the 
highest incidence of epilepsy in children with Zika-related 
microcephaly occurs during the first year and provided new 
insights regarding the development of seizures in the second 
year.
With regard to the age groups, we hypothesized that a 
significant proportion of participants would present with 
early seizures in the first 2 months of life and develop an 
epileptic encephalopathy in the neonatal period, because 
lissencephaly, a common finding in these affected in-
fants, is known to be an important cause of Ohtahara syn-
drome.10,11,28 Nevertheless, we did not observe any record 
of this syndrome in this ZIKV-affected cohort, a finding 
consistent with previous studies.12,13,15 The largest pro-
portion of epileptic seizures occurred between the third 
and ninth months of life, with incidence remaining high 
until the 15th month and very few new cases after this age. 
This age range is typical for when West syndrome usually 
develops, regardless of etiology.29 We observed epileptic 
spasms as the main type of seizure, and, even when a given 
patient presented with another type of associated seizure, 
spasms were the most significant manifestation. However, 
the EEG findings recorded in these cases were not typi-
cal of West syndrome. In epilepsy associated with lissen-
cephaly, spasms are described as the most common type 
of seizure, and the presence of focal or multifocal epilep-
tiform abnormality as the most common electrographic 
pattern,10,11,30 which was reported in our population. The 
spasms described did not always occur in clusters, and 
there were many isolated events occurring at different 
times throughout the day, which presented clinically as 
symmetrical, asymmetrical, or associated with focal signs 
at the beginning or end. The second most common type of 
F I G U R E  2  Electroencephalogram (EEG) samples of different patterns of epileptiform abnormality. A, B, C, EEGs acquired using a 
Neuromap system with the following parameters: high-frequency filter = 70 Hz; low-frequency filter = 0.5 Hz; voltage = 7 µV/mm, velocity = 
30 mm/segment. D, EEG acquired using an EMSA Medical Equipment system with the following parameters: high-frequency filter = 70 Hz; 
low-frequency filter = 0.5 Hz; voltage = 10 µV/mm, velocity = 30 mm/segment. A, Focal epileptiform abnormality. B, Multifocal epileptiform 
abnormality. C, Hypsarrhythmia. D, Multifocal generalized plus epileptiform abnormality
A B
C D
516 |   CARVALHO et AL.
seizure was focal seizures, and these were the predominant 
type in participants for whom onset of epilepsy occurred 
after the first year of life. This finding has not previously 
been reported in the literature. We hypothesize that the ob-
served epilepsy may be related to the severe cortical mal-
formations and calcifications caused by congenital ZIKV 
infections, because the incidence of early epilepsy is higher 
in populations with these findings than the general popu-
lation. We can compare this cohort to children with clas-
sical lissencephaly and other congenital infections, such as 
cytomegalovirus.
Classical lissencephaly is recognized as a neuronal 
migration disorder. The migration and differentiation of 
neurons are critical to appropriate electrophysiological 
functions of the cortex.28,31 The incidence of seizures in 
these cases is approximately 90%, with typical onset be-
fore 6 months of age. Experimental ZIKV infection models 
have demonstrated that ZIKV is a neurotropic virus, with a 
predilection for neuronal progenitor cells. After infection, 
ZIKV interferes with cellular differentiation and survival 
through regulation of genes associated with proliferation 
and apoptosis.32‒35 Thus, congenital ZIKV infection can in-
terrupt the development of neurological tissues, especially 
the cerebral cortex, reduce the neuronal population, and 
lead to reduced cortical mantle thickness, areas of brain tis-
sue gliosis and necrosis, and early calcification with appro-
priate appearance of cytoarchitecture of cortical layers.32‒36 
Consistent with this, neuroimaging studies of CZS cases 
indicate extensive cortical thickness and abnormal pat-
terning of sulci and gyri on the surface of the brain. All of 
these abnormalities may be involved in the development of 
early Zika-related epilepsy. In lissencephalies of the other 
causes, especially those of genetic origin, there is a similar 
abnormal neuronal migration, with loss of cortical architec-
ture and macroscopic simplification of the cortical mantle; 
however, gliosis and calcifications are not observed.28,31 
We hypothesize that these differences may alter clinical 
manifestations, at least in early ages, during which the 
onset of Zika-related seizures was not as frequent. Because 
the participants were primarily severe microcephalic cases 
with major neuroimaging abnormalities, the correlation be-
tween imaging findings and the risk of specific epileptic 
syndromes could not be evaluated in this study.
Other congenital infections are also associated with 
early epilepsy. Individuals with congenital cytomegalovi-
rus infections appear to present a clinical picture similar 
to CZS cases, with overlapping clinical and neuroimaging 
features. The incidence of congenital cytomegalovirus-as-
sociated epilepsy has been reported to vary between 10% 
and 56%,37 and the emergence of seizures has been linked 
to disorders of cortical development, ventriculomegaly, 
and calcifications. In contrast with CZS cases, focal sei-
zures are the most common type associated with congenital 
cytomegalovirus infections.37,38 As the developmental cor-
tical disorders in the current ZIKV cohort were severe and 
extensive, this finding may, in part, explain the observed 
higher incidence and greater severity of epilepsy relative 
to published reports on congenital cytomegalovirus-asso-
ciated epilepsy.37
The role of ZIKV in epileptogenesis is not yet fully under-
stood, but it is well established that congenital infections can 
lead to structural abnormalities in brain tissue. We consider 
that the involvement of the virus in cellular division mecha-
nisms of infected neurons may predispose to changes in cel-
lular electrophysiology, making them hyperexcitable.
In relation to the EEG findings, it should be noted that a 
very small number of participants with spasms presented a 
trace of hypsarrhythmia at some point during the follow-up. 
In the vast majority, however, we observed the presence 
of focal epileptiform abnormality in one or more areas ac-
companied by disorganization of the background cerebral 
rhythms. In some cases, the epileptiform abnormality was 
more varied and multifocal, and generalized paroxysms 
were observed in the same EEG. Extensive cortical ab-
normalities with significant simplification of the grooves 
and ridges and a reduction in the parenchymal volume and 
neuronal population likely provide the anatomical substrate 
for these findings.39 Cortical reduction and simplification 
interfere in the neurophysiology of brain tissue, affecting 
both background brain activity and the generation and am-
plitude of nonphysiological potentials, resulting in a pattern 
of focal epileptiform abnormality with less amplitude, and 
reduced propagation and synchronization of epileptiform 
paroxysms.39
The overall response rate to treatment was poor, with ap-
proximately 20% seizure control in the first year and 30% in the 
second year. The low response rate may have been influenced 
by the medications used, as not all participants had access to 
recommended treatments for epileptic spasms, such as vigab-
atrin, ACTH, and corticosteroids. However, epileptic spasms 
associated with lissencephaly are often refractory to medical 
treatment, including the recommended medications. In a sep-
arate study of children with Zika-related microcephaly, the re-
sponse rate to vigabatrin was also reported to be low (22%).10
The treatment response rate may have been influenced 
by the following factors. First, selection bias may have been 
introduced, as the presence of epileptic seizures may have 
increased adherence to medical follow-up. Nevertheless, 
any potential impact of this bias is mitigated in that all of 
the participants were microcephalic and thereby symptom-
atic with neurological impairments, a presentation that fa-
vors good adherence to the follow-up regardless of epilepsy 
status. Overall, the incidence rate reported here appears to 
be consistent with previously published rates and is a plau-
sible estimate for populations of children with Zika-related 
microcephaly. A second limitation is that the method of 
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diagnosing seizures in our study may have been subject to 
misclassification bias. The affected infants may have had 
subtle seizures, which may not have been recognized by the 
family, or abnormal motor events that may have been errone-
ously reported as seizures. Nevertheless, the detailed history 
of paroxysmal event used here is the primary basis for the di-
agnosis of epilepsy. In addition, the use of home videos was 
useful for minimizing misclassification. In medical practice, 
not all epileptic patients will undergo video EEG evaluation, 
as had occurred in the infants included in this study.
5 |  CONCLUSION
In conclusion, Zika-related microcephaly is associated with 
a high risk of developing epilepsy in the first 2 years of life, 
with an incidence rate of 6.3 per 100 person-months. The 
highest proportion of incident cases (ie, new onset seizures) 
was observed between the fourth and seventh months of life, 
the most common type of seizure was spasm epileptic without 
hypsarrhythmia, and the rate of seizure control was low. The 
probability of developing epilepsy decreased after 12 months, 
and thereafter, most commonly presented as structural focal 
epilepsy, with a low rate of response to treatment.
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